US · CCM
Concord Medical Services Holdings Limited
- Sector
- Healthcare · Medical - Care Facilities
- Headquarters
- Beijing 100013
- Website
- concordmedical.com
Price · as of 2024-12-31
$3.95
Market cap 530.04K
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $46.00 | +1,064.56% |
| Intrinsic Value(DCF) | $1.72 | -56.46% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $5,706.80 | +144,375.95% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $33.30 | $21.88 | $6.01 | $73.50 | $148.70 |
| 2011 | $20.96 | $30.59 | $0.03 | $1.00 | $0.00 |
| 2012 | $23.11 | $33.93 | $39.81 | $216.00 | $104.40 |
| 2013 | $70.21 | $459.08 | $95.31 | $1,847.40 | $2,154.80 |
| 2014 | $52.77 | $3,155.41 | $0.00 | $0.00 | $1,439.40 |
| 2015 | $49.30 | $1,052.47 | $880.60 | $936.80 | $0.00 |
| 2016 | $47.50 | $2,786.36 | $32.71 | $0.00 | $4,283.00 |
| 2017 | $29.80 | $597.78 | $19.12 | $0.00 | $4,933.40 |
| 2018 | $32.40 | $2,077.08 | $0.00 | $0.00 | $11,295.80 |
| 2019 | $23.90 | $194.68 | $0.00 | $0.00 | $0.00 |
| 2020 | $34.60 | $887.87 | $0.00 | $0.00 | $0.00 |
| 2021 | $18.80 | $904.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $13.40 | $313.09 | $0.00 | $0.00 | $0.00 |
| 2023 | $4.40 | $594.02 | $0.00 | $0.00 | $0.00 |
| 2024 | $4.31 | $328.12 | $0.00 | $0.00 | $5,706.80 |
AI valuation
Our deep-learning model estimates Concord Medical Services Holdings Limited's (CCM) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $46.00
- Current price
- $3.95
- AI upside
- +1,064.56%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.72
-56.46% upside
Graham-Dodd
—
— upside
Graham Formula
$5,706.80
+144,375.95% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| CCM | Concord Medical Services … | $3.95 | 530.04K | +8,207% | -56% | — | +144,376% | -0.01 | 0.00 | 0.01 | -10.37 | -0.19 | 0.00 | -20.62% | -138.60% | -80.28% | 29.62% | -42.92% | -10.20% | -1.72 | -2.75 | 0.46 | 0.19 | -10.75 | 355.00% | -2855.00% | 10618.00% | -18065.77% | -0.19 | -66.96% | 0.00% | 0.00% | 0.00% | -6.74 | -4.43 | 9.34 | -1.32 |
| ADTX | Aditxt, Inc. | $0.46 | 9.84K | +128,310,097% | +775,435,055% | — | +4,369,268,359% | 0.00 | 0.02 | 1.28 | 30.55 | -0.01 | 0.02 | -367.95% | -20796.36% | -25708.85% | -276.39% | 7.12% | -89.79% | 0.78 | -3.78 | 0.09 | 35.64 | -0.23 | 3863.00% | -7923.00% | -984.00% | -9785.19% | -0.72 | 4.28% | 0.00% | 0.00% | 8689.62% | 29.64 | 49.27 | -6164.42 | -10.97 |
| CELU | Celularity Inc. | $1.23 | 29.59M | +3,881% | -60% | — | — | -0.47 | 3.05 | 0.50 | -2.17 | — | -3.47 | 72.36% | -70.75% | -106.77% | -232.51% | -41.90% | -41.86% | 7.79 | -6.12 | 0.38 | 0.27 | -1.56 | -7600.00% | 13811.00% | -8464.00% | -24.37% | -0.12 | -7.17% | 0.00% | 0.00% | 0.00% | -2.48 | -14.48 | 1.75 | -10.21 |
| IVF | INVO Fertility, Inc. | $0.95 | 224.52K | +165,168% | +7,886,240% | — | — | -3.04 | 2.17 | 4.23 | -5.15 | -0.62 | -0.96 | 44.00% | -124.40% | -139.25% | -133.37% | -56.16% | -28.01% | 0.78 | -7.69 | 0.07 | 0.05 | -1.28 | 48841.00% | 11625.00% | -3926.00% | -11.43% | -0.17 | -21.88% | 0.00% | 0.00% | 0.00% | -4.53 | -11.65 | 5.63 | -2.40 |
| WORX | SCWorx Corp. | $0.33 | 1.37M | +13,567% | +79% | — | +2,775% | -1.19 | 0.30 | 0.45 | 5.66 | — | -1.00 | 24.95% | -42.13% | -38.01% | -27.24% | -30.41% | -18.00% | 0.01 | -12.09 | 0.27 | 0.26 | -0.26 | -7979.00% | -2143.00% | 3450.00% | -80.45% | -0.59 | -26.18% | 0.00% | 0.00% | 4.34% | -1.02 | -1.19 | 0.43 | -6.83 |
About Concord Medical Services Holdings Limited
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
- CEO
- Jianyu Yang
- Employees
- 595
- Beta
- -1.21
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.72 ÷ $3.95) − 1 = -56.46% (DCF, example).